John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVTB
1301
DELISTED
PrivateBancorp Inc
PVTB
| $1.6M | 0.01% |
45,366
-65,377
| -59% | -$2.21M |
|
1302
First Industrial Realty Trust
FR
$8.41B
| $1.59M | 0.01% |
74,440
+30,321
| +69% | +$650K |
|
|
CTCT
1303
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $1.59M | 0.01% |
41,704
-70,837
| -63% | -$2.79M |
|
|
XOXO
1304
DELISTED
Xo Group Inc
XOXO
| $1.59M | 0.01% |
89,769
+8,937
| +11% | +$151K |
|
1305
PUT
Exelon
EXC
$45.7B
| $1.58M | 0.01% |
+65,894
| New | +$1.63M |
|
|
MON
1306
CALL
DELISTED
Monsanto Co
MON
| $1.58M | 0.01% |
+14,000
| New | +$1.66M |
|
1307
Genworth Financial
GNW
$3.74B
| $1.57M | 0.01% |
215,318
-2,353,852
| -92% | -$17.9M |
|
1308
Northrop Grumman
NOC
$78B
| $1.57M | 0.01% |
+9,771
| New | +$1.56M |
|
1309
PUT
US Bancorp
USB
$97.3B
| $1.57M | 0.01% |
+36,000
| New | +$1.58M |
|
|
AVB
1310
CALL
DELISTED
AvalonBay Communities
AVB
| $1.57M | 0.01% |
+9,000
| New | +$1.56M |
|
1311
Loews
L
$22.8B
| $1.57M | 0.01% |
38,398
-861,236
| -96% | -$34.9M |
|
1312
PUT
Allstate
ALL
$65.8B
| $1.57M | 0.01% |
+22,000
| New | +$1.55M |
|
1313
Central Garden & Pet Co Class A
CENTA
$2.4B
| $1.57M | 0.01% |
184,273
-23,695
| -11% | -$190K |
|
|
NBL
1314
CALL
DELISTED
Noble Energy, Inc.
NBL
| $1.56M | 0.01% |
+32,000
| New | +$1.49M |
|
|
VASC
1315
DELISTED
Vascular Solutions Inc
VASC
| $1.56M | 0.01% |
51,541
+2,934
| +6% | +$84.2K |
|
1316
Deluxe
DLX
$1.1B
| $1.56M | 0.01% |
+22,510
| New | +$1.47M |
|
1317
Cogent Communications
CCOI
$486M
| $1.56M | 0.01% |
44,098
-137,272
| -76% | -$5.02M |
|
1318
Granite Construction
GVA
$5.47B
| $1.56M | 0.01% |
+44,309
| New | +$1.54M |
|
1319
Helen of Troy
HELE
$666M
| $1.55M | 0.01% |
+19,008
| New | +$1.45M |
|
1320
Huron Consulting
HURN
$2.59B
| $1.54M | 0.01% |
23,342
-1,871
| -7% | -$131K |
|
|
DOC
1321
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.54M | 0.01% |
+87,520
| New | +$1.48M |
|
1322
Southwest Airlines
LUV
$19.9B
| $1.54M | 0.01% |
34,704
-366,938
| -91% | -$16M |
|
1323
Phillips 66
PSX
$96.5B
| $1.53M | 0.01% |
19,482
-82,994
| -81% | -$6.09M |
|
|
IIP
1324
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $1.53M | 0.01% |
149,486
+40,587
| +37% | +$415K |
|
1325
Mitsubishi UFJ Financial
MUFG
$248B
| $1.52M | 0.01% |
245,129
+78,016
| +47% | +$463K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.